Skip to content
StockMarketAgent
Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

XRAY stock hub

DENTSPLY SIRONA Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

XRAYis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
2.2B
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
XRAY
In the news

Latest news · XRAY

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E7.5
P25 12.3P50 18.4P75 33.1
Trailing P/En/a
P25 14.9P50 23.2P75 38.5
ROE-37.7
P25 -105.6P50 -46.5P75 -3.1
ROIC5.9
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All XRAY market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
260
Groups with data
11
Currency
USD
Showing 260 of 260 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

25
MetricValue
Cik
0000818479
Company name
DENTSPLY SIRONA Inc.
Country
United States
Country code
US
Cusip
24906P109
Employees
14,000
Employees Change
-1,000%
Employees Change Percent
-6.67
Enterprise value
$4.4B
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Medical Instruments & Supplies
IPO Date
1987-08-12
Isin
US24906P1093
Last refreshed
2026-05-10
Market cap
$2.2B
Market cap category
Mid-Cap
Price
$11
Price currency
USD
Rev Per Employee
262,928.57x
Sector
Healthcare
Sic
3843
Symbol
XRAY
Website
https://www.dentsplysirona.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

12
MetricValue
Earnings Yield
-28.5%
EV Sales Forward
1.19x
EV/EBIT
21.37x
EV/EBITDA
7.84x
EV/FCF
41.91x
EV/Sales
1.18x
FCF yield
4.72%
Forward P/E
7.54x
P/B ratio
1.67x
P/S ratio
0.6x
PEG ratio
1.27x
PS Forward
0.6x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

21
MetricValue
EBIT Margin
5.54%
EBITDA Margin
15.1%
FCF margin
2.83%
Gross margin
48.93%
Gross Profit
$1.8B
Gross Profit Growth
-6.59%
Gross Profit Growth Q
-8.37%
Gross Profit Growth3 Y
-5.42%
Gross Profit Growth5 Y
-0.09%
Net Income
$-628M
Net Income Growth Years
1%
Pretax Margin
-15.54%
Profit Margin
-17.06%
Profit Per Employee
$-44,857
ROA
2.26
Roa5y
2.82
ROCE
5.07
ROE
-37.67
Roe5y
-17.64
ROIC
5.88
Roic5y
5.86

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

24
MetricValue
Cagr10y
-14.62%
Cagr15y
-6.92%
Cagr1y
-16.53%
Cagr20y
-3.92%
Cagr3y
-33.8%
Cagr5y
-29.11%
Div CAGR10
7.87%
Div CAGR3
6.49%
Div CAGR5
9.31%
EPS Growth Years
1
FCF Growth
-62.59%
FCF Growth3 Y
-26.22%
FCF Growth5 Y
-29.96%
OCF Growth
-39.5%
OCF Growth Q
471.43%
OCF Growth10 Y
-4.67%
OCF Growth3 Y
-12.71%
OCF Growth5 Y
-17.66%
Revenue Growth
-1.02x
Revenue Growth Q
0.11x
Revenue Growth Quarters
2x
Revenue Growth Years
0x
Revenue Growth3 Y
-2.17x
Revenue Growth5 Y
1.07x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
$0.65
Assets
$5.2B
Cash
$190M
Current Assets
$1.8B
Current Liabilities
$1.2B
Debt
$2.3B
Debt EBITDA
$3.68
Debt Equity
$1.78
Debt FCF
$22.55
Equity
$1.3B
Interest Coverage
1.91
Liabilities
$3.9B
Long Term Assets
$3.4B
Long Term Liabilities
$2.7B
Net Cash
$-2.2B
Net Cash By Market Cap
$-97.79
Net Debt EBITDA
$3.88
Net Debt Equity
$1.63
Net Debt FCF
$20.72
Tangible Book Value
$-748M
Tangible Book Value Per Share
$-3.73
WACC
6.42

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.53
Inventory Turnover
2.96
Net Working Capital
$683M
Quick ratio
0.67
Working Capital
$638M
Working Capital Turnover
$8.95

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

8
MetricValue
Buyback Yield
0.76%
Dividend Growth
0%
Dividend Growth Years
0%
Dividend per share
$0.48
Dividend Years
32
Dividend Yield
4.36%
Ex Div Date
2025-12-26
Last Dividend
$0.16

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

42
MetricValue
10Y total return
-79.42%
1Y total return
-16.52%
200-day SMA
12.5
3Y total return
-71%
50-day SMA
12
50-day SMA vs 200-day SMA
50under200
5Y total return
-82.09%
All Time High
69.54
All Time High Change
-84.18%
All Time High Date
2021-05-10
All Time Low
0.46
All Time Low Change
2,300.17%
All Time Low Date
1987-11-12
ATR
0.51
Beta
0.94
Beta1y
1.56
Beta2y
0.72
Ch YTD
-3.76
High
11.18
High52
17.18
High52 Date
2025-05-12
High52ch
-35.97%
Low
10.75
Low52
9.85
Low52 Date
2025-11-20
Low52ch
11.68%
Ma50ch
-8.36%
Premarket Change Percent
0.82
Premarket Price
$11.05
Premarket Volume
2,867
Price vs 200-day SMA
-11.98%
RSI
37.89
RSI Monthly
31.93
RSI Weekly
42.8
Sharpe ratio
-0.24x
Sortino ratio
-0.23
Total Return
5.12%
Tr YTD
-3.76
Tr15y
-65.89%
Tr1m
-4.51%
Tr1w
-6.86%
Tr3m
-20.06%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

18
MetricValue
Analyst Count
13
Analyst Count Top
3
Analyst Price Target Top
$17
Analyst Ratings
Hold
Analyst Ratings Top
Strong Buy
Earnings EPS Estimate
$0.28
Earnings EPS Estimate Growth
-34.88
Earnings Revenue Estimate
841,426,464x
Earnings Revenue Estimate Growth
-4.27x
Operating Income
$204M
Operating Income Growth
-16.05
Operating Income Growth Q
-57.75
Operating Income Growth3 Y
-13.57
Operating Income Growth5 Y
-10.69
Operating margin
5.54
Price target
$14.36
Price Target Change
$30.55
Price Target Change Top
$54.55

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

11
MetricValue
Float
199,428,992%
Float Percent
99.55%
Net Borrowing
-173,000,000
Shares Insiders
0.32%
Shares Institutions
109.69%
Shares Out
200,326,683
Shares Qo Q
0.15%
Shares Yo Y
-0.76%
Short Float
10.19%
Short Ratio
5.46
Short Shares
10.14

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

71
MetricValue
Adjusted FCF
$73M
Average Volume
4,292,672.75x
Bv Per Share
6.58
CAPEX
$-164M
Ch10y
-82.19
Ch15y
-71.29
Ch1m
-4.51
Ch1w
-6.86
Ch1y
-19.59
Ch20y
-63.16
Ch3m
-20.06
Ch3y
-73.37
Ch5y
-83.93
Ch6m
-1.61
Change
0.36%
Change From Open
0.36
Close
10.96
Days Gap
0
Depreciation Amortization
352,000,000
Dollar Volume
73,015,591
Earnings Date
2026-05-05
Earnings Time
amc
EBIT
$204M
EBITDA
$556M
EPS
$-3.15
F Score
5
FCF
$104M
FCF EV Yield
2.39x
FCF Per Share
$0.52
Financing CF
-322,000,000
Fiscal Year End
December
Founded
1,899
Goodwill
1,142,000,000
Income Tax
$55M
Investing CF
-168,000,000
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-05-05
Last Report Date
2026-03-31
Last Split Date
2006-07-18
Last Split Type
Forward
Last10k Filing Date
2026-02-26
Ma150
12.03
Ma150ch
-8.56%
Ma20
11.82
Ma20ch
-6.95%
Net CF
-208,000,000
Next Earnings Date
2026-08-06
Open
10.96
Optionable
Yes
P FCF Ratio
21.19
P OCF Ratio
8.22
Payment Date
2026-01-09
Position In Range
58.14
Post Close
11
Postmarket Change Percent
0.45
Postmarket Price
$11.05
Ppne
997,000,000
Pre Close
10.96
Price Date
2026-05-08
Price EBITDA
$3.96
Relative Volume
1.55x
Revenue
3,681,000,000x
SBC By Revenue
0.84x
Share Based Comp
31,000,000
Tax By Revenue
1.49x
Tr20y
-55.01%
Tr6m
-0.19%
Us State
North Carolina
Volume
6,637,781
Z Score
0.97
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

XRAY dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+4.4%
$0.48 annual per share
Payout ratio
n/a
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+9.3%
0 consecutive years of growth
Total shareholder yield
+5.1%
Next ex-dividend date: 2025-12-26
Performance

XRAY stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-16.5%
S&P 500 1Y: n/a
3Y total return
-71.0%
S&P 500 3Y: n/a
5Y total return
-82.1%
S&P 500 5Y: n/a
10Y total return
-79.4%
S&P 500 10Y: n/a
Ownership

Who owns XRAY?

Insider, institutional, and short-interest positioning.

Institutional ownership
+109.7%
Float: +99.6% of shares outstanding
Insider ownership
+0.3%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+10.2%
5.5 days to cover
Y/Y dilution
-0.8%
Negative means the company is buying back shares.
Technical

XRAY momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
37.9
Neutral momentum band
Price vs 200-day MA
-12.0%
50/200-day relationship not available
Beta (5Y)
0.94
Moves roughly with the market
Sharpe ratio
-0.24
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About XRAY

Hub-level FAQ points readers to the deeper analysis pages.

What is the current XRAY stock rating?

DENTSPLY SIRONA Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full XRAY analysis?

The full report lives at /stocks/XRAY/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for XRAY?

The latest report frames XRAY around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the XRAY page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.